Exhibit 10.46

CONFIDENTIAL TREATMENT REQUESTED

WITH RESPECT TO CERTAIN PORTIONS HEREOF

DENOTED WITH “***”

EXECUTION COPY

Dated FEBRUARY 28, 2001

AGREEMENT

BETWEEN

SHELL NEDERLAND CHEMIE B.V.

AND

KRATON POLYMERS NEDERLAND B.V.

FOR THE SUPPLY OF ISOPRENE MONOMER

(Pernis-Isoprene Monomer-Feedstock Agt.)

CONTENTS

		Page
1.	Definitions and Interpretation	1
2.	Supply and Purchase of Product	5
3.	Quality	5
4.	Volumes, Scheduling and Nomination, Procurement of Isoprene	6
7.	Price	11
8.	Invoicing and Payment	13
9.	Term and Termination	13
10.	General	14
11.	Notices	14
12.	Force Majeure	14
13.	Liability	15
14.	Assignment	16
15.	Confidentiality	16
16.	Hardship	17
17.	Severability	17
18.	Governing Law and Arbitration	17
19.	Necessary Approvals	18
20.	Counterparts	18
Attachment I - Isoprene Specifications
Attachment II - Approved suppliers list
Attachment III - Flowmeters

i (Pernis-Isoprene Monomer-Feedstock Agt.)

Attachment IV - Estimated Volume Take-off Scheme (in kilo Tonnes)

Attachment V - Examples for Application of Clause 4.4

Attachment VI - List of Purchaser Affiliates

ii (Pernis-Isoprene Monomer-Feedstock Agt.)

ISOPRENE MONOMER SUPPLY AGREEMENT

THIS AGREEMENT is made February 28th 2001 between:

(1) SHELL NEDERLAND CHEMIE B.V., a company incorporated in the Netherlands having its registered office at the Vondelingenweg 601, 3196 KK Vondelingenplaat, Rotterdam, The Netherlands (hereinafter referred to as “SNC”); and

(2) KRATON POLYMERS NEDERLAND B.V., a company incorporated under the laws of THE Netherlands with its registered office at the Vondelingenweg 601, 3196 KK Vondelingenplaat, Rotterdam, The Netherlands (hereinafter referred to as “PURCHASER”)

RECITALS:

(A) SNC manufactures IP at its plant in Pernis.

(B) PURCHASER and those of its Affiliates listed in Attachment VI hereto require supplies of IP for further processing at various locations in Europe, and wish to have a long-term stable supply of IP.

(C) SNC is willing to supply IP to PURCHASER and PURCHASER is willing to take delivery of IP from SNC on the terms and conditions set out in this Agreement.

(D) Elastomers and Lower Olefins want to co-operate in a global partnership.

IT IS AGREED as follows:

1. Definitions and Interpretation

1.1 In this Agreement, where the context so admits, the following words and expressions shall have the following meanings:

“Affiliate” means in relation to SNC, N.V. Koninklijke Nederlandsche Petroleum Maatschappij, The “Shell” Transport and Trading Company, p.l.c. and any other company other than SNC which is directly or indirectly affiliated with the first mentioned companies or either of them.

(Pernis-Isoprene Monomer-Feedstock Agt.)

	Means in relation to PURCHASER, any company which is directly or indirectly affiliated with PURCHASER.
	For the purposes of this definition, a particular company is:
	(i)     directly affiliated with another company or companies if the latter hold(s) shares or similar entitlements carrying fifty per cent (50%) or more of the votes exercisable at a general meeting of shareholders (or its equivalent) of the particular company; and
	(ii)    indirectly affiliated with a company or companies (“the parent company or companies”) if a series of companies can be specified, beginning with the parent company or companies and ending with the particular company, so related that each company or companies, except the parent company or companies, is directly affiliated with one or more of the companies earlier in the series;
“Agreement”	Means this isoprene monomer supply agreement including its Attachments;
“Berre”	Means PURCHASER’s plant in Berre, France;
“CMR Complex”	Means the chemical plants that fall under the Veiligheidsdistrict Chemie, Monomeren en Rubber, including, but not limited to the isoprene extraction plant and the Kraton plant; which comprises Pernis SIS and Pernis IR;
“EMU Legislation”	Means the legislative measures of the Council of the European Union providing for the introduction of, changeover to, or operation of, the Euro;
“Euro”	Means the single currency of the Participating Member States in the Third Stage;

2 (Pernis-Isoprene Monomer-Feedstock Agt.)

“Flowmeters W, X, Y and Z”	Means the flowmeters referred to in Attachment III;
“ICIS”	Means (Independent Commodity Information Services) the weekly publication of the ICIS-LOR Group;
“IP”	Means isoprene monomer;
“IP/19 Product”	Means IP/19 complying with the specifications set out in Attachment 1;
“IP/60 Product”	Means IP/60 complying with the specifications set out in Attachment 1;
“IP/99 Product”	Means IP acquired from third party producers;
“Month”	Means a calendar month;
“Participating Member States”	Means those member states of the European Union from time to time which adopt a single, shared currency in the Third Stage, as defined and identified in the EMU Legislation;
“Pernis SIS”	Means PURCHASER’s production line in Pernis, The Netherlands which manufactures styrene-isoprene block copolymers;
“Pernis IR”	Means PURCHASER’s production line in Pernis, The Netherlands which manufactures polyisoprene rubber;
“PIR”	Means polyisoprene rubber;
“Platts”	Means Platt’s Marketscan, the daily (UK-workdays) quotations service published by Standard & Poor’s, a Division of The McGraw-Hill Group;
“Polysolvent”	Means the C5 hydrocarbons in any isoprene containing stream that are not isoprene;
“Product”	Means the IP/19 Product, the IP/60 Product and the IP/99 Product with the specifications set out in Attachment I;

3 (Pernis-Isoprene Monomer-Feedstock Agt.)

“Quarter”	Means a period of three consecutive months commencing 1 January, 1 April, 1 July and 1 October in any Year;
“SIS”	Means styrene-isoprene block copolymers;
“Third Party”	Means any third party other than SNC and PURCHASER and their respective Affiliates;
“Three Month Period”	Means a period of three consecutive Months beginning on the first day of the first Month in that period;
“Third Stage”	Means the third stage of European economic and monetary union pursuant to the Treaty establishing the European Community (as amended from time to time);
“Tonne”	Means one thousand kilograms;
“U-2000 Extraction Plant”	Means the isoprene extraction plant which produces raw or untreated isoprene;
“U-3500Treatment Plant”	Means the isoprene Sodium treatment plant which purifies raw isoprene to meet the quality required for polymerisation;
“Volume”	Means the amount of Product supplied by SNC to PURCHASER under this Agreement;
“Wesseling”	Means PURCHASER’s plant in Wesseling, Germany;
“Year”	Means a calendar year.

1.2 References in this Agreement to Clauses and Attachments are to Clauses in and Attachments to this Agreement. The Recitals and Attachments to this Agreement form part of this Agreement.

1.3 Headings are inserted for convenience only and shall not affect the construction of this Agreement.

1.4 The masculine gender shall include the feminine and neuter and the singular number shall include the plural and vice versa.

4 (Pernis-Isoprene Monomer-Feedstock Agt.)

2. Supply and Purchase of Product

2.1 SNC shall, subject to the provisions of sub-clause 4.1, supply to PURCHASER [***] [Confidential Treatment Requested] in aggregate of IP in IP/19 Product and IP in IP/60 Product per Year (which is the present Pernis plant capacity), and PURCHASER shall purchase from SNC [***] [Confidential Treatment Requested] in aggregate of IP in IP/19 Product and IP in IP/60 Product per Year.

2.2 In addition, on request of PURCHASER SNC shall purchase such volume of IP/99 Product as PURCHASER shall request for supply to PURCHASER and PURCHASER shall acquire any such volumes of IP/99 Product so requested. The combined volume of isoprene shall constitute PURCHASER’s total annual demand in Europe. Volumes are listed in 4.1.

2.3 The obligation of PURCHASER to take delivery of PRODUCT may be taken over wholly or in part by one or more of those Affiliates listed in Attachment VI.

3. Quality

3.1 SNC warrants that all Product supplied to PURCHASER shall comply with the specifications set out in Attachment I unless otherwise agreed. In the case of pipeline deliveries, quality data will be supplied to PURCHASER on a regular basis as set out in attachment I.

3.2 In the event that PURCHASER reasonably believes that it has cause to complain that the quality of Product delivered to it pursuant to this Agreement does not comply with the specification set out in Attachment I, PURCHASER shall give written notice specifying the nature of its complaint and the parties shall promptly meet so as to endeavour to resolve that complaint. In the case of non-performance (resulting from a failure to react the isoprene, or continued inability to meet the polymer specifications or from some other cause), a team will be formed on PURCHASER’s request consisting at least of the PURCHASER’s representative at the plant and the assistant plant manager of the monomers plant, as well as the plant manager of the CMR Complex, which team shall have the responsibility to find the cause of non-performance and implement a solution as soon as possible.

3.3 In the event that Product supplied by SNC to PURCHASER is proved to have failed to comply with the specifications set out in Attachment I, PURCHASER shall be entitled at its option to require SNC either (a) to take back and replace such defective Product with Product which meets the specifications as soon as reasonably practicable thereafter or (b) to reimburse the invoice value of the defective Product.

5 (Pernis-Isoprene Monomer-Feedstock Agt.)

3.4 Attachment II contains an approved suppliers list of sources approved by PURCHASER. PURCHASER will indicate to SNC which other suppliers (apart from meeting specifications) can be accepted and added to the approved suppliers list (any such indications not to be unreasonably withheld).

3.5 In the absence of any written notice from PURCHASER to SNC within 15 days after delivery of the Product, the Product shall be deemed to have been delivered and accepted by PURCHASER in a satisfactory condition and in all respects in accordance with the specifications and SNC shall have no liability to PURCHASER with respect to that delivery.

4. Volumes, Scheduling and Nomination, Procurement of Isoprene

4.1 Planning volumes and Agreed Volume

4.1.1 By 1st September in each Year PURCHASER shall submit to SNC a non-binding volume estimate of its requirements for IP IN IP/19 Product and IP IN IP/60 Product for the forthcoming Year and will submit a non-binding estimate for the 4 Years thereafter following the format in Attachment IV.

Forecasts of purchased volumes will be supplied along with information concerning the Agreed Volumes as indicated in 4.2 and 4.3.

4.1.2  As soon as possible thereafter and in any event no later than 1^st October in the same Year SNC and PURCHASER shall agree on the volume of IP/19 Product and IP/60 Product to be purchased and supplied during the forthcoming Year. The volume so determined shall be within the range of Volumes set out in clause 2.1 and, subject to any adjustment required under sub-clause 4.1.3, shall constitute the “Agreed Volume”.

4.1.3 PURCHASER acknowledges that the capability of SNC to supply IP/19 Product and IP/60 Product is determined by the existing capacity of the U-3500 Treatment Plant and that accordingly the Agreed Volume for a given Year [***] [Confidential Treatment Required]

(a) [***] [Confidential Treatment Required]

(b) [***] [Confidential Treatment Required]

[***] [Confidential Treatment Required]

6 (Pernis-Isoprene Monomer-Feedstock Agt.)

[***]  [Confidential Treatment Requested]

4.2 Three month rolling forecast

Subject to Clause 4.1 PURCHASER shall submit to SNC in writing its monthly requirement for each of the IP in IP/19 Product, the IP in IP/60 Product and the IP/99 Product for each Three Month Period, such submission to be made monthly and to be made available to SNC no less than eight working days before the beginning of the first month of each Three Month Period.

Both parties shall use their best endeavours to purchase and supply Product evenly spread throughout the Year.

4.3 Information on shutdowns

PURCHASER and SNC shall notify each other at the earliest opportunity, but not later than twelve months before it occurs, of any planned shutdown or maintenance programme, and its duration, which may affect SNC’s capability to supply, or PURCHASER’s capability to purchase, Product.

4.4 Variations to Agreed Volumes

PURCHASER shall be obliged to purchase and SNC shall be obliged to supply the Agreed Volume of IP in IP/19 Product and IP in IP/60 Product in each Year. In the case of persistent failure of PURCHASER to purchase, or SNC to supply, the Agreed Volume, as the case may be, the party in default of its obligations will immediately inform the other party and both will seek to resolve the problem in mutual agreement minimising the impact on both businesses. Examples are set out in Attachment V.

4.4.1 Demand below Agreed Volumes

If PURCHASER purchases and takes delivery of less than the Agreed Volume determined in accordance with Clause 4.1, and the Volume purchased and delivered [***] [Confidential Treatment Required].

4.4.2 Supply below Agreed Volumes

7 (Pernis-Isoprene Monomer-Feedstock Agt.)

4.4.2.1 If SNC supplies and produces less than the Agreed Volume determined in accordance with clause 4.1, and the Volume supplied and produced (the “Actual Supplied Volume”) [***] [Confidential Treatment Required].

4.4.2.2 SNC shall be obliged to purchase at its own cost additional IP/99 Product in accordance with clause 4.4.2.1 at a price up to and including [***] [Confidential Treatment Required] above the price determined in accordance with clause 7 for supply to the PURCHASER. SNC will not be required to purchase IP/99 Product at more than [***] [Confidential Treatment Required] above the price determined in accordance with clause 7 below. In case SNC cannot purchase IP/99 Product at, or below [***] [Confidential Treatment Required] above the price determined in accordance with clause 7 below, it will inform the PURCHASER of offers received. Should PURCHASER elect to accept the offer, then SNC will purchase this volume and make it available to PURCHASER at purchase price minus [***] [Confidential Treatment Required].

4.4.3 Demand above Agreed Volume

If PURCHASER requires volumes above the Agreed Volume determined in accordance with Clause 4.1, SNC shall have the right, but not the obligation, to supply additional manufactured volumes in accordance to the terms of this contract. If and to the extent that SNC has the capacity to supply such Additional Volumes from its own production facilities, SNC will supply these additional volumes at the price determined in accordance with clause 7. If and to the extent that SNC does not have the capacity to supply such Additional Volumes from its own production facilities, SNC will purchase (if available in the market) that volume and make it available at the purchase price determined in accordance with clause 4.5.

4.5 Purchase of Additional Volumes

Where PURCHASER requires Product in excess of the Agreed Volume, both parties will discuss how best to deal with the additional volume required. This includes discussions of a supplier, prices, quantities and delivery points on short term requirements, each of which as qualified by the PURCHASER. The actual purchase transaction from third parties for Volumes referred to in clauses 2.2 and 4.1 will be done by SNC on behalf of PURCHASER. Where SNC is not able to meet PURCHASER’s requirements for Additional Volumes by own production or

8 (Pernis-Isoprene Monomer-Feedstock Agt.)

purchase of Additional Volumes PURCHASER will have a right to obtain these Additional Volumes from other suppliers. If third party purchases are necessary, SNC and PURCHASER will work together in planning and procurement of Product.

4.6 Handling fee

SNC shall be entitled to charge and PURCHASER shall be obliged to pay a handling fee of [***] [Confidential Treatment Required] on all purchases of IP/99 Product.

4.7 [***] [Confidential Treatment Required] fee

SNC shall be entitled to charge and PURCHASER shall be obliged to pay a treatment fee for any Product that is [***] [Confidential Treatment Required] Plant save for any Product supplied to PURCHASER in accordance with clause 3.2 or 4.4.2.

For any Product supplied under the terms of clause 4.4.2 which requires [***] [Confidential Treatment Required] to be included in any additional cost element relating to compensating supplies will be [***] [Confidential Treatment Required].

Purchased material will normally [***] [Confidential Treatment Required] e.g. during a planned shutdown of the U-2000 Treatment Plant the fee will be [***] [Confidential Treatment Required]. This price will be reviewed should SNC’s cost for [***] [Confidential Treatment Required] significantly. For higher quantities the fee will be negotiated separately.

4.8 Additional Volumes arising from Capacity expansions

Both parties will endeavour to resolve any mismatches arising in Product supply and demand due to the creation by SNC of additional isoprene production capability above and beyond the annual Agreed Volumes or any mismatches arising in Product supply and demand which arise from changes in requirements of PURCHASER. Additional Product volumes will be offered by SNC first to PURCHASER, before additional production commences. If and to the extent that any additional volumes are not acquired by PURCHASER they will be placed by SNC in the merchant market. Where SNC sells those Product volumes in the merchant market at a lower price than the price charged to PURCHASER for Product under clause 7 of this Agreement in the period, then SNC will sell an equivalent quantity of the Product at the same price to PURCHASER, provided that such price equalisation shall not apply where Product which does not meet the relevant specifications set out in Attachment I is disposed of or if PURCHASER

9 (Pernis-Isoprene Monomer-Feedstock Agt.)

does not purchase the Agreed Volume. PURCHASER has at its own cost the right of audit of the Product sales of SNC into the merchant market by an independent surveyor acceptable to both parties. Only in case of significant deviations SNC would carry the costs of such audit.

5. Delivery Terms

5.1 SNC shall deliver Product to Pernis by pipeline from SNC’s storage in Pernis to PURCHASER’s flange at Pernis, The Netherlands on a CPT basis.

5.2 To the extent not inconsistent with any terms of this Agreement, Incoterms (1990 edition) shall apply.

5.3 For supplies to Pernis, title and risk in the Product shall pass from SNC to PURCHASER when the Product passes the permanent connected flow meter, as shown in Attachment III.

5.4 SNC shall supply Product on a [***] [Confidential Treatment Requested] to Berre and Wesseling.

6. Quantity Measurement

6.1 The quantity of Product delivered during any period shall be determined by the Flowmeters and analytical equipment as referred to in Clause 5.3.

The quantity of Product delivered will be determined as follows:

The percentage of IP in IP/19 multiplied by the volume recorded by Flowmeter X, plus

The percentage of IP in IP/60 multiplied by the volume recorded by Flowmeter Y

minus the percentage of IP in the return stream from the Pernis IR unit multiplied by the volume recorded by Flowmeter Z.

6.2 The quantity of Polysolvent delivered during any period shall be determined by the Flowmeters and analytical equipment as mentioned in Clause 5.3.

The quantity of Polysolvent delivered will be determined as follows:

The percentage of Polysolvent in IP/19 multiplied by volume recorded by Flowmeter X, plus

The percentage of Polysolvent in IP/60 multiplied by volume recorded by Flowmeter Y

minus the percentage of Polysolvent in the return stream from the Pernis IR unit multiplied by volume recorded by Flowmeter Z,

10 (Pernis-Isoprene Monomer-Feedstock Agt.)

plus the total amount of the return stream from the Pernis SIS unit as measured by Flowmeter W [note: this will be the stream ex U-4000 to RKW].

6.3 The invoice quantity shall be determined by SNC based on the reading given by its calibrated Flowmeters, or on the level difference in its gauged IP tanks, both corrected for temperature.

6.4 SNC shall be responsible for the upkeep and maintenance of its gauged IP tanks and its calibrated flow meters.

6.5 SNC shall arrange for the testing and calibration of all its gauged IP tanks and calibrated flow meters on a regularly scheduled basis.

6.6 If at any time PURCHASER has reasonable grounds to suspect that any measuring equipment, including the Flowmeters, is not accurate in any respect, the discrepancy or suspected discrepancy shall be immediately reported to SNC in writing along with any evidence in support of such claim and SNC shall arrange for the testing of the relevant piece of measuring equipment.

6.7 If any piece of measuring equipment fails to register or, upon test, is found not to be within +/- 0.5 percent accuracy then, for the purposes of this Agreement, a reasonable adjustment in accordance with generally accepted engineering practices shall be made correcting all measurements made with that piece of measuring equipment. Such adjustments shall reflect, if determinable, the actual period during which any inaccurate measurements were made. If such period cannot be determined it shall be deemed to be such period as shall be equal to one-half of the time from the date of the previous test of such measurement equipment, provided that the period covered by any such correction shall not exceed 6 months.

7. Price

7.1 The Calculated Price, in USD/Tonne, to be paid by PURCHASER to SNC for the supply of IP shall be as given by the following formula:-

[***]  [Confidential Treatment Required]

[***]  [Confidential Treatment Required]

[***]  [Confidential Treatment Required]

[***]  [Confidential Treatment Required]

[***]  [Confidential Treatment Required]

11 (Pernis-Isoprene Monomer-Feedstock Agt.)

[***] [Confidential Treatment Required]

7.2 Prices will be subject where applicable to VAT, Excise Duty and any other government tax or duty.

7.3 Price for Polysolvent is equal to the value [***] [Confidential Treatment Required].

12 (Pernis-Isoprene Monomer-Feedstock Agt.)

7.4 The Euro/Dollar rate (monthly average) as published by Reuter’s –LONDON- 9 A.M. Daily shall apply to convert the Calculated Price in USD/Tonne ex clause 7.1 into an Invoice Price in Euro/Tonne.

8. Invoicing and Payment

8.1 SNC shall issue to PURCHASER an invoice in Euro in respect of each delivery of Product within 5 days after the end of each Month for all deliveries in the past Month in the case of deliveries ex tank or within 5 days after the date of the bill of lading relating to other deliveries, whichever is applicable.

8.2 PURCHASER shall make payment against each invoice in Euro (or any other currency as agreed between the parties) within [***] [Confidential Treatment Required] after the end of Month in case of deliveries ex tank or within [***] [Confidential Treatment Required] of the date of the bill of lading to which the invoice related, whichever is applicable.

8.3 If the appropriate data is not available to calculate the invoice price, the most recently calculated invoice price shall be used for all subsequent deliveries until the correct invoice price can be calculated. If this procedure results in an overcharge or undercharge, an adjustment shall be made to the next invoice for the amount of the overcharge or undercharge.

8.4 In case of any payment obligation owed to SNC by any of PURCHASER’s Affiliates in accordance with this Agreement, PURCHASER shall unconditionally guarantee such payment obligations.

9. Term and Termination

9.1.1 The Agreement shall become effective on the date of this Agreement and shall remain in force until the earlier of termination in accordance with Clause 9.2 below and, subject to sub-clause 9.1.2, 31st December, 2009.

9.1.2 The Agreement will be automatically extended on 31^st December, 2009 and each anniversary of that date thereafter for a period of one (1) year thereafter subject to notice of termination in writing by either party of not less than 24 months, such notice not expire before 31^st Dec 2009.

9.2 If at any time during the term of this Agreement:

9.2.1 Either party goes bankrupt or in liquidation or shall cease to carry on business, the other party may terminate this Agreement with immediate effect.

13 (Pernis-Isoprene Monomer-Feedstock Agt.)

9.2.2 Either party or any of their Affiliates fail to perform their obligations under this Agreement and do not remedy that failure within 60 (sixty) days of receipt of written notice from the other party then the other party shall be entitled (without prejudice to its other rights and remedies) to terminate this Agreement with immediate effect.

10. General

10.1 This Agreement shall be binding upon and shall enure for the benefit of the permitted assignees of the parties.

10.2 No failure to exercise, and no delay or forbearance in exercising, any right or remedy in respect of any provision of this Agreement shall operate as a waiver of such right or remedy.

10.3 Variations of this Agreement shall not be effective unless made in writing signed by duly authorised representatives of the parties.

11. Notices

Any notice required to be given by either party to the other shall be in writing and shall be deemed validly served by hand delivery or by prepaid registered letter, sent through the post to its address given below, or such other address as may from time to time be notified for this purpose and any notice served by hand shall be deemed to have served on delivery, and any notice served by prepaid registered letter shall be deemed to have been served 48 hours after the time of which it was posted, and in proving service it shall be sufficient (in the case of service by hand or prepaid registered letter) to prove that the notice was properly addressed and delivered or posted, as the case may be.

PURCHASER	SNC
KRATON POLYMERS HOLDINGS B.V.	Shell Nederland Chemie B.V.
Vondelingenweg 601	Postbus 3005
NL-3196 KK Vondelingenplaat Rt.	NL-3190 GB Hoogvliet Rt.

12. Force Majeure

12.1 Neither party shall be under any liability to the other whether in contract or in tort due to the first party being delayed or hindered in or prevented from performing any or all of its obligations under this Agreement by reason of fire, explosion,

14 (Pernis-Isoprene Monomer-Feedstock Agt.)

accident, flood, act of God, war, riot, labour dispute, strike, lockout, plant breakdown, shortage or non-availability of raw materials not arising from a conscious and deliberate act on the part of the supplier or any other cause (whether or not of the same nature as the foregoing) not reasonably foreseeable at the date of this Agreement and beyond the reasonable control of the party in question.

12.2 If either party is unable to perform any of its obligations under this Agreement by reason of any of the causes mentioned in Article 12.1 above or if either party considers it likely that it may become so unable, then that party shall as soon as reasonably practicable notify the other of the nature, estimated extent and duration of such inability. In case of any reasonable doubt as to occurrence of any of the causes mentioned in Article 12.1, preventing a party to fulfil its contractual obligations under this Agreement, the other party has the right to have any of such causes confirmed by an independent auditor, subject to the approval of the other party, such approval not to be unreasonably withheld. In such an auditing process, the party declaring Force Majeure will give access to any necessary information available to that party, unless that party is bound by secrecy agreements. However it being explicitly understood that all decisions concerning health, safety and environmental matters shall be at the sole discretion of the party declaring Force Majeure. The party affected by Force Majeure shall use all reasonable efforts to remedy the event of Force Majeure as soon as possible.

12.3 In the event of a shortage of Product due under this Agreement, caused by reasons as defined in Article 12.1, the Volume to be delivered in the period affected by Force Majeure shall be reduced on a pro rata basis with quantities to be delivered under binding contracts in existence at the time the Force Majeure event occurred or could reasonably be anticipated.

12.4 Lack of funds shall not be Force Majeure.

12.5 Neither party shall be entitled to rely on Force Majeure to relieve it from an obligation to pay money which would otherwise be payable under this Agreement (save to the extent and for the period that payment of the same cannot be made by reason of bank strike or similar occurrence).

13. Liability

13.1 Subject to Clause 13.3, in the event that IP supplied under this Agreement does not accord with the specifications set out in Attachment I, SNC shall promptly replace such IP and SNC shall have no other liability in contract or in tort or in any other way for any loss or damage to PURCHASER arising from any act or omission in or relating to the supply or failure to supply IP under this Agreement.

15 (Pernis-Isoprene Monomer-Feedstock Agt.)

13.2 Subject to Clause 13.3, neither party shall be liable to the other for loss of profits, loss of margin, loss of use, loss of contract, loss of good goodwill or any indirect or other consequential losses of any nature whatsoever, whether or not caused by or resulting from the negligence of such party or breach of its statutory duties or a breach of its obligations under this Agreement howsoever caused.

13.3 Nothing in this Agreement shall exclude, restrict or limit any liability of either of the parties for:

(i) death or personal injury resulting from negligence as defined in the Unfair Contract Terms Act 1977; or

(ii) fraud or any other matter if and to the extent that, under English law, liability for it cannot be excluded, restricted or limited as against PURCHASER in the context of this Agreement.

13.4 To the extent that SNC is in breach of any supply obligation under this Agreement, or if SNC has failed to supply Product pursuant to an event of Force Majeure which has, in any case, resulted in a shortfall in supply or failure in supply of Product to PURCHASER under this Agreement, PURCHASER shall, upon prior written notice to SNC of such intention, have the right to purchase elsewhere at its own risk and cost, such quantities of Product as may be necessary to cover the shortfall in its requirements resulting from the shortfall in, or failure to, supply to it during the period of such shortfall or failure to supply.

Any quantities of Product purchased by PURCHASER from Third Parties in this context shall be deducted from the Agreed Volume of Product on an equivalent basis provided PURCHASER gives SNC notice as soon as is reasonably practicable of any such purchase of Product.

14. Assignment

Either Party may at any time, with the prior written consent of the other Party (such consent not to be unreasonably withheld or delayed), assign all or any part of the benefit of, or its rights and benefits under, this Agreement except that no consent shall be required in the case of an assignment to an Affiliate or Affiliates.

15. Confidentiality

Each party shall ensure that unless the other party gives its prior written consent no information regarding the contents of this Agreement shall be disclosed except to an Affiliate and only then, if and to the extent such Affiliate needs to know the terms and conditions of this Agreement. The party in question shall ensure that

16 (Pernis-Isoprene Monomer-Feedstock Agt.)

the Affiliate in question is notified of the confidential nature of this Agreement and that such Affiliate enters into an appropriate confidentiality undertaking.

16. Hardship

If at any time during this Agreement either party is of the view that there has been a substantial change in business, monetary, technical or commercial conditions (excluding changes in the market price of IP and any other of the afore-mentioned changes that are to be borne by either party pursuant to the purpose of this Agreement) as a result of which that party suffers material hardship in complying with this Agreement, that party may notify the other in writing that it wishes to meet and review the conditions of the Agreement in the light of the changed business conditions. The parties shall meet to discuss in good faith appropriate means, if any, to alleviate or mitigate the effects of such hardship in a manner equitable to both parties.

17. Severability

17.1 If any of the provisions of this Agreement is or becomes illegal, void or unenforceable under the law of any jurisdiction, such provision shall be deemed to be deleted from this Agreement and the remaining provisions of this Agreement shall remain and continue in full force and effect.

17.2 The invalidity of one or more provisions of this Agreement shall not affect:-

(A) the legality, validity or enforceability in that jurisdiction of any other provision of this Agreement; or

(B) legality, validity or enforceability under the law of any other jurisdiction of that or any other provision of this Agreement.

18. Governing Law and Arbitration

18.1 This Agreement shall be governed by and construed in accordance with English law.

18.2 In the event any dispute, controversy, or difference of opinion arises between the parties hereunder out of or in relation to or in connection with this Agreement or the breach thereof, the parties agree that all disputes arising in connection with the present Agreement shall be finally settled under the rules of conciliation and arbitration of the International Chamber of Commerce in Paris by three (3) arbitrators appointed in accordance with those rules. The place of arbitration shall be Rotterdam and the language shall be English.

17 (Pernis-Isoprene Monomer-Feedstock Agt.)

19. Necessary Approvals

19.1 As soon as reasonably practicable after signature of this Agreement, both parties agree to co-operate in notifying the Agreement to the EC commission for negative clearance and/or exemption pursuant to Article 81 (3) of the EC Treaty.

19.2 The parties will negotiate in good faith with the Commission and with each other any amendment to the arrangements contemplated by this Agreement (or any other arrangements between the parties or their associates) relevant to the joint notification referred to in Clause 19.1 requested by the Commission in order to obtain the negative clearance or exemption so requested. If no agreement can be reached all rights and obligations under this Agreement shall cease to exist.

20. Counterparts

20.1 This Agreement may be executed in any number of counterparts, and by the Parties on separate counterparts, but shall not be effective until each Party has executed at least one counterpart.

20.2 Each counterpart shall constitute an original of this Agreement, but all the counterparts shall together constitute but one and the same instrument.

18 (Pernis-Isoprene Monomer-Feedstock Agt.)

IN WITNESS whereof this document has been signed by duly authorised persons on behalf of the Parties the day and year first before written.

SHELL NEDERLAND CHEMIE B.V. Rotterdam	KRATON POLYMERS NEDERLAND B.V. Rotterdam
/s/    Illegible	/s/    Illegible
Illegible	Illegible

(Pernis-Isoprene Monomer-Feedstock Agt.)

ATTACHMENT I

ISOPRENE SPECIFICATIONS

1. Purchase Specifications [***] [Confidential Treatment Required]

Product ZIP 1919% concentrate of Isoprene, article number X2106
DESCRIPTION	UNIT	TARGET	SPECIFICATION
			Min	Max
***	% wt	***	***	***
***	ppm	***		***
***	ppm	***		***
***
***	BuLi eq ltr	***	***	***
***	-	***	***
***	-	***	***
***	-	***	***
***	-	***	***

*) maximum value is related to reaction safety, target to be agreed depending on level of variation of IP concentration

**) level of killing is equivalent to the use of a certain amount of titration BuLi (12% concentrate); 1 liter BuLi equivalent is representative for the following level of known killers in the feed, if only that killer would be present. Realising that a mixture of killers is present the levels should be lower than this. Note, not all killers are known or measurable with present state of the art analytical techniques.

1	***	***	ppm
2	***	***	ppm
3	***	***	ppm
4	***	***	ppm
5	***	***	ppm
6	***	***	ppm
7	***	***	ppm
8	***	***	ppm

[***] [Confidential Treatment Required]

1 (Pernis-Isoprene Monomer-Feedstock Agt.)

***) the number of runs that can be achieved is a measure for slow killers, present in the [***] [Confidential Treatment Required]. The runs as specified are defined within CMR/3 Q-system, and relate to the polymer MW.

2. Solvent Specifications

2.1 Return Stream from Pernis IR Code X2036

DESCRIPTION	UNIT	TARGET	SPECIFICATION
			Min	Max
***	% wt	-	***	***
***	Ppm	-	***	***
***	% wt			***
***		***

In principle the polysolvent will not be modified physically and/or chemically during production of IR.

2.2 n-Pentane Code Q116

PROPERTY	SPEC	UNIT	SPECIFICATION
			Min	Max
***	***	kg/m3	***	***
***	***	-	***	***
***	***	% m/m	***
***	***	% m/m		***
***	***	% m/m		***
***	***	mg/kg		***
***	***	clear
***	***	mg/kg		***

In principle the n-Pentane will not be modified physically and/or chemically during production of IR.

[***] [Confidential Treatment Required]

2 (Pernis-Isoprene Monomer-Feedstock Agt.)

3. Isoprene 99% purity (IP99) Code X2154 (Supplier is [***] [Confidential Treatment Required])
PROPERTY	SPEC	UNIT	SPECIFICATION
			Min	Max
***	***	% m/m	***
***	***	mg/kg		***
***	***	mg/kg		***
***	***	mg/kg		***
***	***	mg/kg		***
***	***	mg/kg		***
***	***	mg/kg		***
***	***	mg/kg		***
***	***	mg/kg		***
***	***	mg/kg		***
***	***	mg/kg		***
***	***	mg/l		***
***	***	mg/kg		***
***	***	mg/kg		***
***	***	% m/m		***
***	***	mg/kg		***
***	***	mg/kg		***
***	***	% m/m		***
***	***	Pt/Co scale		***

PROPERTY	SPEC	UNIT	SPECIFICATION
			Min	Max
***	***	% m/m	***
***	***	% m/m		***
***	***	% m/m		***
***	***	mg/kg		***
***	***	mg/kg		***
***	***	mg/kg		***
***	***	mg/kg		***
***	***	mg/kg		***
***	***	mg/kg		***

[***] [Confidential Treatment Required] impurity specifications based on [***] [Confidential Treatment Required] of IP99 [***] [Confidential Treatment Required] Impurity specifications.

[***] [Confidential Treatment Required]

3 (Pernis-Isoprene Monomer-Feedstock Agt.)

4. QUALITY ASSURANCE

4.1 NORMAL OPERATION

It is realised by both parties that specifications can only be applied during normal operation, after strict procedures regarding start-up have been applied.

4.2 Change Management

SNC agrees to notify PURCHASER at least 3 months in advance of any changes in manufacturing, chemical composition, raw material sources, contract processing and testing methods, which may affect the performance of the Product.

PURCHASER agrees to notify SNC at least 3 months in advance of any changes in manufacturing, chemical composition, raw material sources, contact processing and testing methods, which may affect the performance of the Polysolvent.

4.3 Quality Reporting

A set of performance determining parameters for IP/19 Product and IP/60 Product will be defined. These parameters, and the reporting thereof, will be included in the CMR quality systems.

4 (Pernis-Isoprene Monomer-Feedstock Agt.)

ATTACHMENT II

APPROVED SUPPLIERS LIST

/Supplier Consumer/	***	***	***	***	***	***	***	***
Berre	***							***
Wesseling	***							***
Pernis	***	***				***	***
Belpre		***		***	***		***

*=Can only be used after sodium treatment in U-3500 in Pernis

[***] [Confidential Treatment Required]

5 (Pernis-Isoprene Monomer-Feedstock Agt.)

ATTACHMENT III

FLOWMETERS

The Flowmeters W,X,Y,Z will be installed by SNC after divestment. For the meantime the Isoprene and Polysolvent quantities will be determined applying actual practice.

After specification and engineering a process flow scheme indicating the location of the Flowmeters will be attached as Attachment III.

6 (Pernis-Isoprene Monomer-Feedstock Agt.)

ATTACHMENT IV

ESTIMATED VOLUME TAKE-OFF SCHEME (IN KILO TONNES)

	1999 (pro rata)				2000	2001	2002	2003
Contract Total
Estimated Annual Volume be 1st October in any year	Q1	Q2	Q3	Q4	***	***	***	***
Pernis					***	***	***	***
Berre (*)					***	***	***	***
Wesseling					***	***	***	***

(*) incl. Infineum requirement

[***] [Confidential Treatment Required]

7 (Pernis-Isoprene Monomer-Feedstock Agt.)

EXECUTION COPY

ATTACHMENT V

EXAMPLES FOR APPLICATION OF CLAUSE 4.4

Assumptions:

Agreed volume was [***] [Confidential Treatment Required] and SNC undersupplies by [***] [Confidential Treatment Required]. In all examples the first [***] [Confidential Treatment Required] is excluded from this arrangement. SNC will purchase Third Party material at PURCHASER’s request, as per clause 2.2. For the remaining [***] [Confidential Treatment Required] examples are given for different market conditions that describe how product would be purchased by SNC and transferred to PURCHASER.

1

[***] [Confidential Treatment Required]

[***] [Confidential Treatment Required]

Result: [***] [Confidential Treatment Required]

2

Third Party A price is [***] [Confidential Treatment Required]

Third Party B material is [***] [Confidential Treatment Required]

Result: [***] [Confidential Treatment Required]

3

Third Party A price is [***] [Confidential Treatment Required]

Third Party B material is [***] [Confidential Treatment Required]

Result: [***] [Confidential Treatment Required]

8 (Pernis-Isoprene Monomer-Feedstock Agt.)

4

Third Party price is [***] [Confidential Treatment Required]

[***] [Confidential Treatment Required] is available but needs treating first. [***] [Confidential Treatment Required]

Result: [***] [Confidential Treatment Required]

5

Third Party price is [***] [Confidential Treatment Required] (Pernis formula) [***] [Confidential Treatment Required] is available but needs treating first. [***] [Confidential Treatment Required] price [***] [Confidential Treatment Required]; freight is [***] [Confidential Treatment Required]. Treating cost is [***] [Confidential Treatment Required]. Result: [***] [Confidential Treatment Required]

9 (Pernis-Isoprene Monomer-Feedstock Agt.)